Skip to content
Screener

Net Income at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$299.1M+25.5%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
-$14.28M-26.7%
Sotera Health logo
Sotera HealthSHC
$53.64M+574%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$46.71M+22.5%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-$13.2M+96.5%
Revvity logo
RevvityRVTY
$40.72M-3.6%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025Six Months Ended / June 27, 2026Six Months Ended / June 28, 2025
Other (expense) income, net(37,410)154(161,540)(12,057)
Income before income taxes53,17071,41823,228107,396
Provision for income taxes53,93018,72538,79028,825
Net income (loss)(760)52,693(15,562)78,571
Less: Net income attributable to noncontrolling interests722367763776
Net income (loss) attributable to common shareholders$(1,482)$52,326$(16,325)$77,795
Earnings (loss) per common share
Basic$(0.03)$1.06$(0.34)$1.56

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's net income?
Charles River Laboratories (CRL) reported net income of -$760K in Q2 2026.
How has Charles River Laboratories's net income changed year-over-year?
Charles River Laboratories's net income decreased by 101.4% year-over-year, from $52.69M to -$760K.
What is the long-term trend for Charles River Laboratories's net income?
Over 3 years (2021 to 2025), Charles River Laboratories's net income has grown at a -29.1% compound annual growth rate (CAGR), from $398.84M to -$142.16M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.

Ask your AI about Charles River Laboratories's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude